Search results for "Hyperintensity"

showing 10 items of 60 documents

Prevalence and Cognitive Impact of Medial Temporal Atrophy in a Hospital Stroke Service: Retrospective Cohort Study

2015

Background Cerebrovascular disease and neurodegeneration cause cognitive impairment and frequently coexist. Aims Our objectives were to investigate the prevalence and cognitive impact of medial temporal lobe atrophy – a radiological marker often associated with Alzheimer's disease – in a hospital stroke service. Methods Retrospective cohort study of patients from a hospital stroke service. Patients assessed for suspected ischemic stroke or transient ischemic attack, irrespective of final diagnosis, underwent neuropsychological testing and magnetic resonance imaging. medial temporal lobe atrophy, white matter hyperintensities, lacunes, and cerebral microbleeds were rated using established cr…

Malemedicine.medical_specialtyPathologyPopulationNeuropsychological TestsSeverity of Illness IndexBrain IschemiaInternal medicinePrevalencemedicineHumansCerebral amyloid angiopathyeducationVascular dementiaStrokeRetrospective Studieseducation.field_of_studymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingRetrospective cohort studyOdds ratioMiddle Agedmedicine.diseaseMagnetic Resonance ImagingTemporal LobeHyperintensityHospitalizationStrokeLogistic ModelsNeurologyMultivariate AnalysisCardiologyFemaleAtrophyVerbal memoryCognition DisordersbusinessMedial temporal lobe atrophyInternational Journal of Stroke
researchProduct

Neurological complications of Anderson-Fabry disease

2012

Characteristic clinical manifestations of AFD such as acroparesthesias, angiokeratoma, corneal opacity, hypo/ and anhidrosis, gastrointestinal symptoms, renal and cardiac dysfunctions can occur in male and female patients, although heterozygous females with AFD usually seems to be less severely affected. The most prominent CNS manifestations consist of cerebrovascular events such as transient ischaemic attacks (TIAs) and (recurrent) strokes . For the most part, CNS complications in AFD have been attributed to cerebral vasculopathy, including anatomical abnormalities. The natural history of Fabry patients includes transitory cerebral ischaemia and strokes, even in very young persons of both …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPopulationTransient ischaemic attacksPulvinarSeverity of Illness IndexInternal medicineDrug DiscoverymedicinePrevalenceHumanseducationStrokeDepression (differential diagnoses)Pharmacologyeducation.field_of_studySex Characteristicsbusiness.industryAge Factorsmedicine.diseaseFabry diseaseHyperintensitySurgeryAngiokeratomaStrokePeripheral neuropathyIschemic Attack TransientCerebrovascular Circulationalpha-GalactosidaseCardiologyFabry DiseaseFemaleAnderson-Fabry disease Neurological strokebusiness
researchProduct

How specific are the pontine MRI hyperintensities (the cross sign)?

2003

Nuclear magnetic resonanceNeurologymedicine.diagnostic_testbusiness.industrymedicineMagnetic resonance imagingNeurology (clinical)medicine.diseasebusinessHyperintensityMyasthenia gravisSign (mathematics)European Journal of Neurology
researchProduct

Covarying patterns of white matter lesions and cortical atrophy predict progression in early MS

2020

ObjectiveWe applied longitudinal 3T MRI and advanced computational models in 2 independent cohorts of patients with early MS to investigate how white matter (WM) lesion distribution and cortical atrophy topographically interrelate and affect functional disability.MethodsClinical disability was measured using the Expanded Disability Status Scale Score at baseline and at 1-year follow-up in a cohort of 119 patients with early relapsing-remitting MS and in a replication cohort of 81 patients. Covarying patterns of cortical atrophy and baseline lesion distribution were extracted by parallel independent component analysis. Predictive power of covarying patterns for disability progression was tes…

OncologyAdultMalemedicine.medical_specialtySupport Vector Machine41Article312LesionWhite matterText miningMultiple Sclerosis Relapsing-RemittingInternal medicineCerebellumMedicineHumansLongitudinal StudiesCerebral CortexExpanded Disability Status Scalemedicine.diagnostic_testbusiness.industryMultiple sclerosisMagnetic resonance imagingMiddle Agedmedicine.diseasePrognosisMagnetic Resonance ImagingWhite MatterHyperintensitymedicine.anatomical_structureNeurologyCohortDisease ProgressionFemaleNeurology (clinical)medicine.symptomAtrophybusinessNeurology® Neuroimmunology & Neuroinflammation
researchProduct

The presence of white matter lesions is not associated with non-alcoholic fatty liver disease but with its histological severity

2015

Pathologymedicine.medical_specialtyHepatologybusiness.industryFatty liverGastroenterologyMedicineNon alcoholicDiseasebusinessmedicine.diseaseHyperintensityDigestive and Liver Disease
researchProduct

P1030 : The presence of white matter lesions is not associated with non-alcoholic fatty liver disease but with its histological severity

2015

Pathologymedicine.medical_specialtyHepatologybusiness.industryFatty liverMedicineNon alcoholicDiseasebusinessmedicine.diseaseHyperintensityJournal of Hepatology
researchProduct

Camptocormia associated with focal myositis in multiple-system atrophy

2005

Camptocormia (CC) or pronounced forward flexion of the trunk is a common symptom of Parkinson's disease. We describe 2 patients with probable, respectively possible multiple-system atrophy and CC. Magnetic resonance imaging of the erector trunci showed focal patchy hyperintensities with gadolinium enhancement and muscle biopsy was indicative of variably pronounced focal myositis. CC was progressive and the major handicap for both patients after 1 and 1.5 years of follow-up, respectively. The therapeutic response was poor. Similarities with the dropped-head syndrome suggest that the muscle pathology may be either the primary cause of CC, a focal reaction to the CC posture, or a coincident sy…

Pathologymedicine.medical_specialtyMuscle biopsymedicine.diagnostic_testbusiness.industryMagnetic resonance imagingmedicine.diseaseTrunkHyperintensityCamptocormiaAtrophyNeurologyBiopsymedicineNeurology (clinical)businessMyositisMovement Disorders
researchProduct

Cerebral microbleeds and vascular cognitive impairment

2010

Abstract MRI manifestations of small vessel diseases including white matter hyperintensities and lacunes have been recognized as potential substrates of vascular cognitive impairment for many years. Cerebral microbleeds (CMBs) – small, perviascular haemorrhages seen as small, well-demarcated, hypointense, rounded lesions on MRI sequences sensitive to magnetic susceptibility effects – are also now recognized as an imaging marker for small vessel pathology, but their clinical impact on cognition remains uncertain. CMBs are present in about a third of patients with ischaemic stroke, and in a high proportion of patients with Alzheimer's disease, cerebral amyloid angiopathy, and vascular dementi…

Pathologymedicine.medical_specialtybusiness.industryVascular diseaseDementia VascularCognitive disordermedicine.diseasecerebral microbleeds vascular cognitive impairmentMagnetic Resonance ImagingHyperintensityCentral nervous system diseaseDegenerative diseaseNeurologyHumansMedicineDementiaNeurology (clinical)Cerebral amyloid angiopathyCognition DisordersbusinessVascular dementiaCerebral Hemorrhage
researchProduct

[Psychomotor disadaptation syndrome].

2014

We describe the psychomotor disadaptation syndrome and report the last findings on its physiopathology and therapeutic. This syndrome was first described by Pr Gaudet's team in 1986 and named "psychomotor regression syndrome". This name has been recently changed into "psychomotor disadaptation syndrome".The psychomotor disadaptation syndrome is a decompensation of postural function, gait and psychomotor automatisms due to the alteration of the posture and motor programming. That alteration is linked to subcortical-frontal lesions. Clinically, the psychomotor disadaptation syndrome is characterized by postural impairments (retro-propulsion or backward disequilibrium), non-specific gait disor…

Pediatricsmedicine.medical_specialtyAgingPopulationPosturePoison controlROTTERDAM SCANCEREBRAL VASOMOTOR REACTIVITYDISEASEDiagnosis DifferentialAGEPhysical medicine and rehabilitationPEOPLEmedicineHumansDecompensationeducationELDERLY-PATIENTSPostural BalanceGait Disorders NeurologicPOPULATIONBiological PsychiatryAgedAged 80 and overPsychomotor learningeducation.field_of_studyMovement DisordersHYPERTENSIONABNORMALITIESbusiness.industryfood and beveragesAnhedoniaSyndromeWHITE-MATTER LESIONSPrognosisGaitHyperintensityNeuropsychology and Physiological PsychologySensation DisordersHypertoniaAccidental Falls[ SCCO ] Cognitive scienceNeurology (clinical)Geriatrics and Gerontologymedicine.symptomPsychomotor DisordersbusinessLa Revue de medecine interne
researchProduct

Genotype–phenotype correlation in a new Fabry-disease-causing mutation

2019

Background: Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by α-galactosidase A deficiency leading to intracellular glycosphingolipid accumulation. FD manifestation is multisystem, and can differ depending on disease-related genetic variants. Currently, more than 700 different FD-causing mutations have been identified in the human GLA gene. We identified a novel mutation in a Lithuanian family with classical manifestations of Fabry disease, revealing severe effects to the cardiovascular systems of heterozygous women. Case presentation: A 49-year-old woman underwent echocardiography due to progressive dyspnea that lasted seven years, reduced physical a…

Probandmedicine.medical_specialtyAbdominal painMedicine (General)α-galactosidase ACase ReportLeft ventricular hypertrophyGastroenterologyclassical manifestationR5-920Internal medicinemedicineGLA geneFabry diseasemedicine.diagnostic_testbusiness.industryCardiac arrhythmiaGeneral MedicineFabry disease ; α-galactosidase A ; GLA gene ; novel mutation ; classical manifestationmedicine.diseaseFabry diseaseHyperintensityMutation (genetic algorithm)<i>GLA</i> geneRenal biopsymedicine.symptomnovel mutationbusiness
researchProduct